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Abstract

Background: The risk of alcohol use disorder increases after bariatric surgery. Preoperative alcohol
use is a risk factor, and this is evaluated during the routine preoperative psychosocial evaluation.
However, it is not clear whether patients accurately report their alcohol use.
Objective: To determine whether an objective measure of alcohol use, phosphatidylethanol (PEth)
testing, offers utility beyond self-reported alcohol use during the preoperative evaluation for bariatric
surgery.
Setting: Single healthcare system.
Methods: PEth testing was included as part of the routine laboratory work for 139 patients undergoing evaluation for bariatric surgery. PEth testing results were compared with self-reported alcohol use
and scores on the Alcohol Use Disorders Identification Test–Concise (AUDIT-C) questionnaire obtained during the preoperative psychosocial evaluation. PEth testing results were categorized into
abstinent, light use, moderate use, or heavy use. There were 85 patients who completed both PEth
testing and a preoperative psychosocial evaluation.
Results: There were 25 participants (29.4%) who had a positive PEth test; about half had moderate or
heavy use values (15.3% of the total sample). The majority of participants with a positive PEth test
(82.6%) denied recent alcohol use. Of those with PEth values indicating moderate or heavy use,
61.5% did not have an elevated AUDIT-C score.
Conclusions: Patients appeared to underreport their alcohol use during the preoperative psychosocial evaluation. There appears to be utility for routine PEth testing as part of the evaluation process
to identify those with risky drinking patterns. Patients with preoperative risky drinking could be
educated about their risk and/or referred to programs to mitigate the development of preoperative
alcohol misuse. (Surg Obes Relat Dis 2022;-:1–7.) Ó 2022 American Society for Metabolic and
Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
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Bariatric surgery is the most effective treatment for patients with severe obesity [1]. In addition to sustainable
weight loss, bariatric surgery has many potential benefits
for patients, including the treatment and prevention of
many co-morbid medical conditions, such as diabetes mellitus, hypertension, dyslipidemia, cardiovascular disease,
and sleep apnea [2,3]. It is a widely used obesity treatment,
with an estimated 256,000 bariatric surgeries performed in
the United States in 2019 alone [1].
Despite the success of bariatric surgery for the treatment
of patients with obesity and other co-morbid medical conditions, one serious consequence is the increased risk of developing an alcohol use disorder (AUD) after surgery [4,5].
Previous studies have shown that more than half of patients
consume alcohol postoperatively, of which the majority
begin to use between 6 and 12 months after surgery [6].
However, the rates of alcohol use and AUDs continue to increase as patients progress from surgery [4,7]. There are
multiple proposed rationales for the higher risk of developing an AUD postoperatively in bariatric populations.
One proposed reason is pharmacokinetic changes that occur
postoperatively that result in faster and higher increases in
blood alcohol concentration and decreased elimination rates
[8–10]. Additionally, individuals have reported an increased
sensitivity to the effects of alcohol postoperatively,
requiring fewer drinks to feel the desired effects of
intoxication from alcohol than prior to surgery [11,12].
The existing literature suggests several risk factors for
developing an AUD postoperatively, including male sex,
younger age, tobacco and recreational drug use, and lower
sense of belonging within the social community [13,14].
Most notably, individuals with a history of an AUD and recreational preoperative alcohol use are more likely to resume
alcohol use postoperatively and have a postoperative AUD
[4,14,15]. In addition, more than half of patients consume
alcohol after surgery, and this is despite understanding
that they are at an increased risk of developing an AUD
[6]. Unfortunately, because most patients drink and we are
not able to predict who will develop an AUD postoperatively
with high specificity, many patients remain at high-risk for
an AUD.
Given the increased risk of postoperative alcohol misuse
and an AUD, it is recommended that clinicians thoroughly
assess for alcohol use during preoperative psychosocial
evaluations [16]. However, clinical interviews might miss
a large portion of patients at risk for postoperative alcohol
use because many patients underestimate their substance
use [17,18]. Further, those undergoing a psychosocial evaluation prior to bariatric surgery may be motivated to underreport their alcohol use to obtain clearance for surgery.
Given this, we may miss individuals who may be drinking
at higher levels prior to surgery, and thus, those at highest
risk of developing alcohol misuse or an AUD postoperatively will not be identified. A more objective measure of

alcohol use may be helpful at identifying those at high
risk for a postoperative AUD during the preoperative
evaluation.
In other preoperative evaluations (e.g., transplant), clinicians are beginning to use phosphatidylethanol (PEth)
testing as an objective measure of alcohol use. PEth testing
is a blood test that measures PEth levels, which are biomarkers made only in the presence of alcohol [19,20].
PEth testing has many benefits. Because it has a direct relationship with alcohol consumption, it has high sensitivity
(i.e., up to 100% for alcohol consumed in the prior week)
and high specificity at rates of up to 100% [19–21]. In
addition, it has benefits over other objective measures of
alcohol use. Specifically, it provides information regarding
alcohol use over a longer period (i.e., the previous 2–4
weeks) and also provides values that signify level of
drinking (i.e., abstinent/light, moderate, and heavy use)
[20,22]. Thus, it has been recommended as a more specific
and sensitive measure of alcohol use in comparison with
self-reports and other biological methods [18]. Use of
PEth testing in bariatric surgery patients is very new, and
to our knowledge, there are only 2 studies to date. Similar
to the aforementioned studies, these suggest that PEth
testing can identify recent alcohol use among those undergoing bariatric surgery; although they did not examine
how PEth results relate to self-reported alcohol use
[23,24]. Despite the use of PEth testing in preoperative evaluations for other populations, it is not used routinely as an
objective measure of alcohol use among those pursuing bariatric surgery. Because PEth testing can provide an objective
estimate of recent alcohol use, it could be a useful tool as
part of the preoperative evaluation process (i.e., to identify
those with risky preoperative alcohol use who are at highrisk for postoperative alcohol misuse). However, the utility
of PEth testing has not yet been explored. There is limited
research on the use of PEth testing for preoperative evaluations, and given the cost of PEth testing and laboratory analyses, further research is needed to determine whether there
are benefits to PEth testing that could justify the cost. Thus,
the purpose of this study was to determine the feasibility of
including PEth testing as a routine part of the preoperative
bariatric evaluation process and whether using routine
PEth testing offers information beyond self-reported alcohol
use during the preoperative psychosocial evaluation.
Methods
Participants and procedure
Retrospective chart reviews were conducted on all 139
patients who were planning to complete their preoperative
evaluation and undergo bariatric surgery at a single urban
Midwestern health system. The nurse coordinators of this
program who order the routine preoperative laboratory
work for candidates also were to include PEth testing as a
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part of routine practice. To assess for feasibility, it was
recorded whether the test was ordered. It also was documented whether a test was completed and, if applicable,
the result. Data were also collected from the routine preoperative psychosocial evaluation note in the patients’ electronic health records. Psychosocial evaluations were
conducted by a licensed clinical psychologist or a psychology trainee (i.e., intern or practicum student) supervised by
a licensed clinical psychologist. This included data documented from a semistructured interview and scores on brief
measures. This project was approved by the healthcare system’s institutional review board. Informed consent was
waived due to the retrospective nature of the study.
Measures
PEth test. The nurse coordinators ordered PEth testing as
a part of the routine laboratory work that is conducted as a
part of the preoperative evaluation process. PEth testing was
conducted as a part of routine patient care, and no patients
asked to opt out. As a part of this study, the cost of PEth
testing was covered by a grant. PEth testing requires a blood
sample (collected with the sample used for other routine
preoperative laboratory work) and was run by ARUP Laboratories in Salt Lake City, Utah, using quantitative liquid
chromatography/tandem mass spectrometry. It was documented whether a PEth test was completed, and if so, the
test results were coded as negative (i.e., abstinent) or positive. If positive, the associated value also was recorded.
PEth values indicate light use (10–19 ng/mL), moderate
use (20–199 ng/mL), or heavy use (.200 ng/mL). Based
on research, those with light use likely would have
consumed ,2 drinks per day, those with moderate use
would have consumed approximately 2–3 drinks per day,
and those with heavy use would have consumed at least 4
drinks per day [18,20]. Those with moderate and heavy
PEth values meet the National Institute on Alcohol Abuse
and Alcoholism criteria of risky drinking (i.e., .7 or .14
drinks in a week for women or men, respectively).
Self-reported alcohol use. Data regarding self-reported
alcohol use were collected from the preoperative psychosocial evaluation note written by a licensed psychologist or
psychology trainee supervised by the psychologist. During
the evaluation, the patients were asked to report when the
last use of alcohol occurred, how often they consume
alcohol, and typical number of drinks consumed per sitting.
Alcohol use was coded into the following variables: (1)
recent use (i.e., whether or not a patient consumed alcohol
in the prior month), (2) average number of standard drinks
per sitting, and (3) frequency of drinking (whether a patient
consumed alcohol at least once per week or less frequently
than once per week).
Alcohol Use Disorders Identification Test–Concise.
Scores from the Alcohol Use Disorders Identification
Test–Concise (AUDIT-C) [25] were recorded from the
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preoperative psychosocial evaluation note. This is a 3-item
screening measure to assess for hazardous drinking over
the previous year. Scores of 3 for women or 4 for men
were considered to be elevated.
Analyses
SPSS Software version 25 (IBM, Armonk, NY) was used
to conduct analyses. Frequencies and descriptives were conducted to obtain percentages and means of variables. Chisquared analyses, Fisher exact tests (when cells had ,5
cases), and independent-samples t tests were used to
examine whether there were differences between PEth test
results and self-reported alcohol use during the semistructured interview or on the AUDIT-C. There were missing
data for 13 patients (15.3%) for whether they consumed
alcohol in the prior month, 11 of whom had a negative
PEth test. These patients were excluded from analyses
comparing PEth test results with recent alcohol use. There
were missing AUDIT-C scores for 6 patients (7.1%), 1 of
whom had a positive PEth test; these patients were excluded
from these respective analyses.
Results
Fig. 1 shows the flow of participants in this study. Of the
139 charts reviewed for this study, there were 107 patients
(77.0%) who completed PEth testing. One patient did not
have PEth testing ordered with the routine laboratory
work, and the other 31 patients discontinued the program
prior to having laboratory work completed. Of the 107

Fig. 1. Participants in the study.
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Table 1
Demographics of sample (n 5 85)
Factor

Mean

Standard deviation

Age, yr
Preoperative body mass index, kg/m2
Factor
Sex
Female
Male
Race
White
Black
Other/multiracial
PEth test
Negative
Positive
PEth value category for positive tests
(n 5 25)
Light use (10–19 ng/mL)
Moderate use (20–199 ng/mL)
Heavy use (2001 ng/mL)

44.05
47.9
%

11.41
7.58
n

80
20

68
17

62.4
34.1
3.5

53
29
3

70.6
29.4

60
25

48
40
12

12
10
3

PEth 5 phosphatidylethanol.

patients who had PEth tests, 22 patients did not complete a
psychosocial evaluation. One patient had a provider outside
the health system complete the psychosocial evaluation, and
the other 21 patients chose not to continue in the program
prior to completing the psychosocial evaluation. Thus, there
were data for 85 patients who completed both a PEth test
and a preoperative psychosocial evaluation. Data were
missing for only 1 patient who continued to move forward
in the program (PEth testing was not ordered).
Demographics for this sample are located in Table 1.
There were 25 patients who had a positive PEth test. PEth
values ranged from 10 to 549 ng/mL. Though about half
of patients with a positive PEth test had values indicative
of light drinking, slightly more than half of patients had
values in the moderate or heavy drinking ranges, which
constituted 15.3% (n 5 13) of the entire sample (Table 1).
Table 2 compares PEth test results with self-reported
alcohol use. The majority of patients with a positive PEth
test denied recent alcohol use, which was a similar rate to
that of those with a negative PEth test. Of those with moderate or heavy PEth values, 76.9% (n 5 10) denied recent
alcohol use. With regard to frequency of drinking, those
with a positive PEth test were more likely to endorse drinking at least once per week compared with those with a negative test (Table 2). However, of those with a positive PEth
test, more than half reported drinking less than once per
week. Among those in the moderate to heavy drinking categories, about half reported consuming alcohol less than
weekly (46.2%; n 5 6). There were no significant differences between those with a positive PEth test (mean 5
2.48; standard deviation [SD] 5 1.56) and a negative PEth
test (mean 5 2.59; SD 5 3.56) for the average number of
drinks per sitting reported (t 5 .14; P 5 .89).

Having an elevated AUDIT-C score was not significantly
associated with a positive PEth test value, although those
with moderate and heavy PEth values may be more likely
to have an elevated AUDIT-C score (Table 2). In comparing
PEth test results with the AUDIT-C scores, 76.0% (n 5 19)
of those with a positive PEth test did not have an elevated
AUDIT-C score (Table 2). Of those in the moderate or heavy
use range, 61.5% (n 5 8) did not have an elevated AUDIT-C
score. In addition, there were no significant differences in
AUDIT-C scores between those who had PEth values in
the light, moderate, and heavy drinking ranges (F 5 2.08;
P 5 .15).
Discussion
Considering the high incidence of alcohol use after bariatric surgery and the increased risk that postoperative alcohol
use poses, this study sought to determine whether routine
PEth testing during the preoperative evaluation might offer
utility beyond self-reported alcohol use. In this study, PEth
testing was a highly feasible component to add to routine
preoperative bariatric evaluations; all but one patient who
continued on in the program had PEth testing ordered and
completed. Moreover, as hypothesized, PEth testing
appeared to provide valuable information regarding alcohol
use that likely would have gone undetected using solely selfreported use. Specifically, about 30% of patients exhibited
positive PEth test values, and of these individuals, the vast
majority denied recent alcohol use. PEth testing also indicated that 15.3% of patients were engaging in risky drinking
behaviors, which is double a previously noted estimate
(7.6%) using AUDIT scores [5]. Additional work is needed
with a larger sample size to determine whether PEth testing
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Table 2
PEth test result and self-reported alcohol use

PEth test
Negative
Positive
PEth value category
Abstinent
Light use
Moderate use
Heavy use

PEth test
Negative
Positive
PEth value category
Abstinent
Light use
Moderate use
Heavy use

PEth test
Negative
Positive
PEth value category
Abstinent
Light use
Moderate use
Heavy use

c2

P value

4
4

1.35

.25

4
1
2
1

*

.30

c2

P value

Denied
alcohol use
in prior
month

Reported
alcohol
use in
prior
month

%

n

%

n

91.8
82.6

45
19

8.2
17.4

91.8
90.0
80.0
66.7

45
9
8
2

8.2
10.0
20.0
33.3

Drink less
than
weekly

Drink
weekly or
more

%

n

%

88.3
60.0

53
15

11.7
40.0

7
10

88.3
75.0
60.0
0.0

53
9
6
0

11.7
25.0
40.0
100.0

7
3
4
3

n
8.85

.003

*

,.001

c2

P value

No elevated
AUDIT
score

Elevated
AUDIT
score

%

n

%

n

92.7
79.2

51
19

7.3
20.8

4
5

3.04

.08

92.7
100.0
70.0
33.3

51
11
7
1

7.3
0.0
30.0
66.7

4
0
3
2

*

.01

PEth 5 phosphatidylethanol.
* Fisher exact test was conducted owing to multiple cells having ,5
cases.

continues to find a higher prevalence of preoperative risky
drinking than has been reported previously.
Findings from this study suggest that patients underreport
their alcohol use. Furthermore, most patients who engaged
in risky drinking, as identified by PEth results, did not report
such use, highlighting its important utility. This is consistent
with prior research that suggested that individuals in the
general population tend to underestimate their alcohol use
for a variety of reasons, including poor recall of past consumption, inaccuracy in estimating standard drink sizes
and alcohol content, or being reluctant to report heavier
use [26,27]. Interestingly, those with positive PEth tests reported drinking a similar number of drinks per sitting
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compared with those with negative PEth tests. Perhaps those
who were currently drinking felt a greater motivation to
conceal their alcohol use. Indeed, individuals with an
AUD also appear to underreport their drinking; this may
be a consequence of difficulty recalling use accurately,
motivation by social desirability, or fear of judgment or being denied treatment [28,29].
In this study, the AUDIT-C screener appeared to detect a
greater proportion of those who fell into the moderate or severe range of recent alcohol use on PEth testing compared
with self-reported use during the semistructured interview.
Similarly, using PEth testing in conjunction with selfreported alcohol use on the AUDIT-C enhances the ability
to detect patients with co-morbid health conditions (e.g.,
hepatitis C infection, HIV infection) who may be at
increased risk for mortality [30]. However, it appears that
PEth testing outperformed both the interview and the
AUDIT-C screener in detecting risky use. Specifically,
two-thirds of those with a moderate or heavy PEth value
(i.e., risky drinking) would not have been identified by the
AUDIT-C. Thus, relying on self-reported use as assessed
by a clinical interview and/or screener may fail to detect a
number of high-risk patients. This also may explain why
our finding of risky drinking was more than double the prior
estimate based on elevated AUDIT scores [5]. The results of
this study suggest that a combination of clinical interview,
standardized screening (i.e., AUDIT), and objective
biomarker determinations (i.e., PEth testing) would most
accurately identify those engaging in risky drinking behaviors. Though the full AUDIT could be used and may be better at identifying alcohol use disorders, the AUDIT-C is
briefer and performs similarly to the full-scale questionnaire
at identifying heavy drinking [31]. Interviewing family
members regarding the patient’s alcohol use also could be
considered. Because preoperative alcohol use is associated
with risky postoperative drinking [5,15], preoperative identification of these individuals is critical. Incorporating PEth
testing into the routine preoperative evaluation would increase the likelihood of detecting these individuals and connecting them with supportive care to mitigate the risk of
problematic drinking postoperatively. For example, if patients have a high PEth value, clinicians could provide education regarding what risky drinking is and discuss options
if patients are interested in resources for decreasing alcohol
use. Identifying and appropriately managing problematic
alcohol use prior to bariatric surgery may be associated
with positive outcomes postoperatively [32]. However, additional work is needed with larger sample sizes prior to establishing guidelines around the use of PEth testing, as well as
best-practice strategies for delivering patient education
about high-PEth-value risky drinking.
This study is not without its limitations. The study
collected data through a retrospective chart review and
thus was subject to missing data. For example, we did not
have the date of last alcohol use and AUDIT-C scores for
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all patients. However, the clinicians conducting the psychosocial clinical interviews would have been likely to document significant alcohol use had it been reported. In
addition, some of the PEth tests were conducted outside
the 4 weeks of the psychological evaluation. It is possible
that some of those with elevated PEth tests may have
stopped drinking prior to self-reporting use; though it still
appears that frequency and amount may have been underreported, and recent moderate or heavy use is still a risk factor
for postoperative misuse. Future studies also could benefit
from more structured data collection. By documenting specific time frames and amounts of alcohol use, future researchers may be better able to determine how well selfreports align with PEth test values. For example, 4 patients
with a negative PEth test endorsed alcohol use in the prior
month; this could have been due to a low amount of drinking
more remote from the testing. In addition, 4 patients had
elevated AUDIT-C scores but a negative PEth test. This
was likely due to differing time frames; AUDIT-C asks
about alcohol use over the previous year, whereas PEth
testing is measured over the prior month. It is possible
that those patients discontinued their alcohol use in preparation for surgery. Finally, the current sample size was relatively small. Although a similar investigation should be
repeated with a larger sample, the present pilot findings
are promising in supporting the use of PEth testing as an
objective measure of alcohol use during preoperative evaluations for bariatric surgery.
Conclusion
PEth testing provides an objective measure of alcohol use
that may offer utility beyond self-reported alcohol use and
assist in the identification of individuals who may be at
greater risk for postoperative AUDs. Identifying at-risk individuals and guiding them to effective treatments prior to surgery may decrease the incidence of postoperative AUDs.
Future work could evaluate the predictive validity of preoperative PEth testing for postoperative AUDs.
Disclosures
This project was funded by the Fund for Henry Ford
Health. The authors have no commercial associations that
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